PAUL A FRIEDMAN Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for PAUL A FRIEDMAN.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of PAUL A FRIEDMAN. PAUL A FRIEDMAN is an Chief Executive Officer in INCYTE CORP ($INCY) and a Director in INCYTE CORP ($INCY) and a Director in ALEXION PHARMACEUTICALS INC ($ALXN) and an Chief Executive Officer in SYNTA PHARMACEUTICALS CORP ($SNTA) and a Director in SYNTA PHARMACEUTICALS CORP ($SNTA) and a Director in Cerulean Pharma Inc. ($CERU) and a Director in Verastem, Inc. ($VSTM) and a Director in Prelude Therapeutics Inc ($PRLD).

Address: 3160 PORTER DRIVE PALO ALTO 94304 CA

Companies in which PAUL A FRIEDMAN is an Insider

ALEXION PHARMACEUTICALS, INC.

Trading Symbol: ALXN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PAUL A FRIEDMAN: Director
Holdings: 10,345 shares
Current Value: $1,321,263
Latest Transaction: May 18 2020
$ALXN Market Capitalization: $28.30B
$ALXN Previous Close: $127.72

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 3x
Sell: 0x
Shares Bought: 7,619
Shares Sold: 0
Share Difference: +7,619
Value Difference: $0

Dare Bioscience, Inc.

Trading Symbol: DARE
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PAUL A FRIEDMAN: Director
Holdings: 18,819 shares
Current Value: $21,830
Latest Transaction: Apr 05 2017
$DARE Market Capitalization: $36.49M
$DARE Previous Close: $1.16

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 3x
Sell: 0x
Shares Bought: 18,819
Shares Sold: 0
Share Difference: +18,819
Value Difference: -$14,999

INCYTE CORP

Trading Symbol: INCY
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of PAUL A FRIEDMAN: Director, Chief Executive Officer
Holdings: 256,813 shares
Current Value: $30,350,160
Latest Transaction: May 28 2020
$INCY Market Capitalization: $23.12B
$INCY Previous Close: $118.18

Last 4 weeks trend: SELL
Last 3 months trend: SELL View transactions

Last 3 Months Overview:
Buy: 8x
Sell: 6x
Shares Bought: 202,802
Shares Sold: 228,507
Share Difference: -25,705
Value Difference: +$21,057,007

MADRIGAL PHARMACEUTICALS, INC.

Trading Symbol: SNTA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PAUL A FRIEDMAN: Chief Executive Officer, Director
Holdings: 161,128 shares
Latest Transaction: Feb 23 2021

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 5x
Sell: 2x
Shares Bought: 880,769
Shares Sold: 147,052
Share Difference: +733,717
Value Difference: +$41,304,048

Prelude Therapeutics Inc

Trading Symbol: PRLD
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PAUL A FRIEDMAN: Director
Holdings: 347,522 shares
Latest Transaction: Jun 22 2021

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 4x
Sell: 0x
Shares Bought: 896,740
Shares Sold: 0
Share Difference: +896,740
Value Difference: $0

Verastem, Inc.

Trading Symbol: VSTM
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PAUL A FRIEDMAN: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 16 2016
$VSTM Market Capitalization: $44.39M
$VSTM Previous Close: $1.24

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of PAUL A FRIEDMAN

Sentiment: All, ALXN, DARE, INCY, SNTA, PRLD, VSTM

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 22 2021PRLDPrelude Therapeuti ...FRIEDMAN PAUL ADirectorOption ExerciseA31.0223,344724,13123,344
Feb 23 2021SNTAMADRIGAL PHARMACEU ...FRIEDMAN PAUL AChief Executive Off ...Option ExerciseA119.4950,0005,974,50050,000
Sep 30 2020PRLDPrelude Therapeuti ...FRIEDMAN PAUL ADirectorOption ExerciseC0.00152,57600
Sep 30 2020PRLDPrelude Therapeuti ...FRIEDMAN PAUL ADirectorOption ExerciseC0.00295,79400
Sep 30 2020PRLDPrelude Therapeuti ...FRIEDMAN PAUL ADirectorOption ExerciseP0.0076,2880152,576
Sep 30 2020PRLDPrelude Therapeuti ...FRIEDMAN PAUL ADirectorBuyC0.00152,5760500,098347.5 K to 500.1 K (+43.90 %)
Sep 30 2020PRLDPrelude Therapeuti ...FRIEDMAN PAUL ADirectorBuyC0.00295,7940347,52251.7 K to 347.5 K (+571.83 %)

View all PAUL A FRIEDMAN insider transactions.